{"id":5838,"date":"2021-08-16T12:42:26","date_gmt":"2021-08-16T12:42:26","guid":{"rendered":"https:\/\/www.adacyte.com\/?p=5838"},"modified":"2024-03-05T16:45:40","modified_gmt":"2024-03-05T15:45:40","slug":"gedii-2020","status":"publish","type":"post","link":"https:\/\/www.adacyte.com\/fr\/gedii-2020\/","title":{"rendered":"GEDII 2020"},"content":{"rendered":"
\n

GEDII 2020 : Adacyte Therapeutics ses exp\u00e9riences en Rectolite H\u00e9morragique<\/strong><\/h2>\n<\/div>\n\n
\n

Cascais a \u00e9t\u00e9 pendant quelques jours la capitale portugaise de la Maladie Inflammatoire chronique de l\u2019Intestin. La ville a accueilli la derni\u00e8re R\u00e9union Annuelle du Groupe Portugais d\u2019\u00c9tude sur les Maladies Inflammatoires Intestinales (GEDII 2020)<\/strong>. Du 22 au 24 janvier, des professionnels de diff\u00e9rents pays qui se consacrent \u00e0 l\u2019\u00e9tude de ces maladies se sont r\u00e9unis ici pour partager leurs exp\u00e9riences, \u00e9changer leurs connaissances et conna\u00eetre les nouveaut\u00e9s de l\u2019approche de la rectocolite h\u00e9morragique et de la maladie de Crohn. Dans le cadre de notre engagement \u00e0 aider les professionnels de la sant\u00e9 \u00e0 traiter l\u2019inflammation chronique de ses patients atteints de Rectocolite H\u00e9morragique, Adacyte Therapeutics<\/strong> n\u2019a pas manqu\u00e9 le rendez-vous. Durant deux journ\u00e9es intensives, des efforts ont \u00e9t\u00e9 d\u00e9ploy\u00e9s pour faire conna\u00eetre le b\u00e9n\u00e9fice clinique et le profil de s\u00e9curit\u00e9 d’Adacolumn<\/a><\/strong>. Ce traitement non pharmacologique a prouv\u00e9 qu’il r\u00e9duisait l\u2019inflammation en \u00e9liminant les leucocytes de la circulation sanguine. Ce traitement permet de r\u00e9duire la charge inflammatoire sans risque d\u2019effets secondaires. Notre \u00e9quipe s\u2019est principalement occup\u00e9e de jeunes et moins jeunes m\u00e9decins gastro-ent\u00e9rologues, de p\u00e9diatres, de chirurgiens et d\u2019infirmi\u00e8res.<\/p>\n<\/div>\n\n

\n

Contenus R\u00e9union GEDII 2020<\/strong><\/h2>\n<\/div>\n\n
\n

De nombreux autres profils de professionnels, nationaux et internationaux, ont particip\u00e9 \u00e0 cette r\u00e9union interdisciplinaire. Le premier jour de GEDII 2020<\/strong> a eu lieu la deuxi\u00e8me \u00e9dition des cours intensifs organis\u00e9s par le groupe de jeunes m\u00e9decins du GEDII. L\u2019objet de ce cours \u00e9tait cette ann\u00e9e consacr\u00e9 \u00e0 la maladie de Crohn p\u00e9rianale. \u00c0 cette occasion, l\u2019accent a \u00e9t\u00e9 mis sur l\u2019approche multidisciplinaire qu\u2019exige le sujet. Comme lors des pr\u00e9c\u00e9dentes \u00e9ditions les infirmi\u00e8res ont \u00e9galement tenu une place importante. La r\u00e9union des Infirmi\u00e8res a \u00e9t\u00e9 consacr\u00e9e au r\u00f4le central de l\u2019H\u00f4pital de Jour de Gastro-ent\u00e9rologie lors de la d\u00e9couverte chez un patient d\u2019une MICI.<\/p>\n<\/div>\n\n

\n

Puis, \u00e0 partir de la deuxi\u00e8me journ\u00e9e, s\u2019est d\u00e9roul\u00e9 le congr\u00e8s principal. Lors de cette r\u00e9union, les sp\u00e9cificit\u00e9s de la pathologie p\u00e9diatrique, le probl\u00e8me des comorbidit\u00e9s et les \u00e9volutions dans le domaine des MICI des nouveaux m\u00e9dicaments et, surtout, les nouvelles strat\u00e9gies th\u00e9rapeutiques ont \u00e9t\u00e9 abord\u00e9es. Le microbiome, expression d\u2019un avenir prometteur pour nos patients, a pris une place d’honneur.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

GEDII 2020 : Adacyte Therapeutics ses exp\u00e9riences en Rectolite H\u00e9morragique Cascais a \u00e9t\u00e9 pendant quelques jours la capitale portugaise de la Maladie Inflammatoire chronique de l\u2019Intestin. La ville a accueilli la derni\u00e8re R\u00e9union Annuelle du Groupe Portugais d\u2019\u00c9tude sur les Maladies Inflammatoires Intestinales (GEDII 2020). Du 22 au 24 janvier, des professionnels de diff\u00e9rents pays […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-5838","post","type-post","status-publish","format-standard","hentry","category-events"],"acf":{"h_removemb":false,"imgs":{"img_desktop":5839,"img_mobile":5843},"text_above_title":"","description":""},"yoast_head":"\nGEDII 2020 - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/fr\/gedii-2020\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GEDII 2020 - Adacyte\" \/>\n<meta property=\"og:description\" content=\"GEDII 2020 : Adacyte Therapeutics ses exp\u00e9riences en Rectolite H\u00e9morragique Cascais a \u00e9t\u00e9 pendant quelques jours la capitale portugaise de la Maladie Inflammatoire chronique de l\u2019Intestin. La ville a accueilli la derni\u00e8re R\u00e9union Annuelle du Groupe Portugais d\u2019\u00c9tude sur les Maladies Inflammatoires Intestinales (GEDII 2020). Du 22 au 24 janvier, des professionnels de diff\u00e9rents pays […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/fr\/gedii-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-16T12:42:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-05T15:45:40+00:00\" \/>\n<meta name=\"author\" content=\"Adacyte\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Adacyte\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.adacyte.com\/fr\/gedii-2020\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/fr\/gedii-2020\/\"},\"author\":{\"name\":\"Adacyte\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f\"},\"headline\":\"GEDII 2020\",\"datePublished\":\"2021-08-16T12:42:26+00:00\",\"dateModified\":\"2024-03-05T15:45:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.adacyte.com\/fr\/gedii-2020\/\"},\"wordCount\":421,\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"articleSection\":[\"Events\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/fr\/gedii-2020\/\",\"url\":\"https:\/\/www.adacyte.com\/fr\/gedii-2020\/\",\"name\":\"GEDII 2020 - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2021-08-16T12:42:26+00:00\",\"dateModified\":\"2024-03-05T15:45:40+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/fr\/gedii-2020\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f\",\"name\":\"Adacyte\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g\",\"caption\":\"Adacyte\"},\"url\":\"https:\/\/www.adacyte.com\/fr\/author\/adacyte\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GEDII 2020 - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/fr\/gedii-2020\/","og_locale":"fr_FR","og_type":"article","og_title":"GEDII 2020 - Adacyte","og_description":"GEDII 2020 : Adacyte Therapeutics ses exp\u00e9riences en Rectolite H\u00e9morragique Cascais a \u00e9t\u00e9 pendant quelques jours la capitale portugaise de la Maladie Inflammatoire chronique de l\u2019Intestin. La ville a accueilli la derni\u00e8re R\u00e9union Annuelle du Groupe Portugais d\u2019\u00c9tude sur les Maladies Inflammatoires Intestinales (GEDII 2020). Du 22 au 24 janvier, des professionnels de diff\u00e9rents pays […]","og_url":"https:\/\/www.adacyte.com\/fr\/gedii-2020\/","og_site_name":"Adacyte","article_published_time":"2021-08-16T12:42:26+00:00","article_modified_time":"2024-03-05T15:45:40+00:00","author":"Adacyte","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Adacyte","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.adacyte.com\/fr\/gedii-2020\/#article","isPartOf":{"@id":"https:\/\/www.adacyte.com\/fr\/gedii-2020\/"},"author":{"name":"Adacyte","@id":"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f"},"headline":"GEDII 2020","datePublished":"2021-08-16T12:42:26+00:00","dateModified":"2024-03-05T15:45:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.adacyte.com\/fr\/gedii-2020\/"},"wordCount":421,"publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"articleSection":["Events"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/fr\/gedii-2020\/","url":"https:\/\/www.adacyte.com\/fr\/gedii-2020\/","name":"GEDII 2020 - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2021-08-16T12:42:26+00:00","dateModified":"2024-03-05T15:45:40+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/fr\/gedii-2020\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f","name":"Adacyte","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g","caption":"Adacyte"},"url":"https:\/\/www.adacyte.com\/fr\/author\/adacyte\/"}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/posts\/5838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/comments?post=5838"}],"version-history":[{"count":0,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/posts\/5838\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=5838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/categories?post=5838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/tags?post=5838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}